                         SEQUENCE LISTING

<110>  Inoviq Ltd.
 
<120>  METHODS RELATING TO TUMOUR-DERIVED EXTRACELLULAR VESICLES

<130>  533931PCT

<150>  AU2021901359
<151>  2021-05-06

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  121
<212>  PRT
<213>  Escherichia coli

<220>
<223>  native B subunit of AB5

<400>  1

Ala Met Ala Glu Trp Thr Gly Asp Ala Arg Asp Gly Met Phe Ser Gly 
1               5                   10                  15      


Val Val Ile Thr Gln Phe His Thr Gly Gln Ile Asp Asn Lys Pro Tyr 
            20                  25                  30          


Phe Cys Ile Glu Gly Lys Gln Ser Ala Gly Ser Ser Ile Ser Ala Cys 
        35                  40                  45              


Ser Met Lys Asn Ser Ser Val Trp Gly Ala Ser Phe Ser Thr Leu Tyr 
    50                  55                  60                  


Asn Gln Ala Leu Tyr Phe Tyr Thr Thr Gly Gln Pro Val Arg Ile Tyr 
65                  70                  75                  80  


Tyr Lys Pro Gly Val Trp Thr Tyr Pro Pro Phe Val Lys Ala Leu Thr 
                85                  90                  95      


Ser Asn Ala Leu Val Gly Leu Ser Thr Cys Thr Thr Ser Thr Glu Cys 
            100                 105                 110         


Phe Gly Pro Asp Arg Lys Lys Asn Ser 
        115                 120     


<210>  2
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SubBdeltaS106/deltaT107 mutant

<400>  2

Glu Trp Thr Gly Asp Ala Arg Asp Gly Met Phe Ser Gly Val Val Ile 
1               5                   10                  15      


Thr Gln Phe His Thr Gly Gln Ile Asp Asn Lys Pro Tyr Phe Cys Ile 
            20                  25                  30          


Glu Gly Lys Gln Ser Ala Gly Ser Ser Ile Ser Ala Cys Ser Met Lys 
        35                  40                  45              


Asn Ser Ser Val Trp Gly Ala Ser Phe Ser Thr Leu Tyr Asn Gln Ala 
    50                  55                  60                  


Leu Tyr Phe Tyr Thr Thr Gly Gln Pro Val Arg Ile Tyr Tyr Lys Pro 
65                  70                  75                  80  


Gly Val Trp Thr Tyr Pro Pro Phe Val Lys Ala Leu Thr Ser Asn Ala 
                85                  90                  95      


Leu Val Gly Leu Ser Thr Cys Thr Thr Glu Cys Phe Gly Pro Asp Arg 
            100                 105                 110         


Lys Lys Asn Ser 
        115     


<210>  3
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  glycan binding motif of the native B subunit of AB5

<400>  3

Thr Thr Ser Thr Glu 
1               5   


<210>  4
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SubB2M

<400>  4

Glu Trp Thr Gly Asp Ala Arg Asp Gly Met Phe Ser Gly Val Val Ile 
1               5                   10                  15      


Thr Gln Phe His Thr Gly Gln Ile Asp Asn Lys Pro Tyr Phe Cys Ile 
            20                  25                  30          


Glu Gly Lys Gln Ser Ala Gly Ser Ser Ile Ser Ala Cys Ser Met Lys 
        35                  40                  45              


Asn Ser Ser Val Trp Gly Ala Ser Phe Ser Thr Leu Tyr Asn Gln Ala 
    50                  55                  60                  


Leu Tyr Phe Tyr Thr Thr Gly Gln Pro Val Arg Ile Tyr Tyr Glu Pro 
65                  70                  75                  80  


Gly Val Trp Thr Tyr Pro Pro Phe Val Lys Ala Leu Thr Ser Asn Ala 
                85                  90                  95      


Leu Val Gly Leu Ser Thr Cys Thr Thr Glu Cys Phe Gly Pro Asp Arg 
            100                 105                 110         


Lys Lys Asn Ser 
        115     


